(Q49592937)

21 February 2018

title

Tumor Immuno-Environment in Cancer Progression and Therapy. (English)

1 reference

21 February 2018

author name string

Pawel Kalinski

series ordinal

1

1 reference

21 February 2018

James E Talmadge

series ordinal

2

1 reference

21 February 2018

language of work or name

English

0 references

publication date

1 January 2017

1 reference

21 February 2018

Advances in Experimental Medicine and Biology

number of pages

18

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 February 2018

volume

1036

1 reference

21 February 2018

page(s)

1-18

1 reference

21 February 2018

Radiotherapy and immunotherapy: a beneficial liaison?

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Role of Local Radiation Therapy in Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Current perspectives on immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

PD-1 blockade induces responses by inhibiting adaptive immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Influence of tumour micro-environment heterogeneity on therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tissue biomarkers as prognostic variables of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Immunotherapy of cancer in 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The biology and function of fibroblasts in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Regulation of the anti-tumour immune response by cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The changing paradigm of tumour response to irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

B cell regulation in cancer and anti-tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Phenotype, effector function, and tissue localization of PD-1-expressing human follicular helper T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Targeting natural killer cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Targeting natural killer cells and natural killer T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The role of natural killer cells in immune surveillance of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Simultaneous gastrointestinal stromal tumor and mucosa-associated lymphoid tissue lymphoma of the stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

New vistas on macrophage differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Macrophage polarization comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Other functions, other genes: alternative activation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Regulation of immune responses by prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Intratumoral macrophage counts correlate with tumor progression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor-associated macrophages: the double-edged sword in cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Alternative activation of macrophages: an immunologic functional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

VEGF as a mediator of tumor-associated immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Myeloid-Derived Suppressor Cells in Human Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Clinical use of dendritic cells for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Development of vaccines for high-risk ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

21 January 2018

DC-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Next generation of immunotherapy for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Prostate cancer immunotherapy: beyond immunity to curability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Increasing the efficacy of tumor cell vaccines by enhancing cross priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Migration of dendritic cell based cancer vaccines: in vivo veritas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Dendritic cell dysfunction in cancer: a mechanism for immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The adaptive immunologic microenvironment in colorectal cancer: a novel perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Prognostic and predictive impact of intra- and peritumoral immune infiltrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumors and inflammatory infiltrates: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Immune infiltration in human tumors: a prognostic factor that should not be ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Natural killer cells in human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Perforin is required for innate and adaptive immunity induced by heat shock protein gp96.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Do Natural Killer Cells Engage in Regulated Reactions Against Self to Ensure Homeostasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Antibody-based immunotherapy for ovarian cancer: where are we at?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Colorectal cancer vaccines in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Immunotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Brain tumor immunotherapy with type-1 polarizing strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

21 January 2018

Cancer Statistics, 2017.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

An immune-active tumor microenvironment favors clinical response to ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

Macrophage content of tumours in relation to metastatic spread and host immune reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-67577-0_1

10.1007/978-3-319-67577-0_1

21 January 2018

Identifiers

DOI

1 reference

21 February 2018

1 reference

21 February 2018